Dermata Therapeutics Stock Forward View - Simple Moving Average
| DRMAW Stock | USD 0.02 0.0018 10.91% |
The successful prediction of Dermata Therapeutics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Dermata Therapeutics Warrant, which may create opportunities for some arbitrage if properly timed.
As of today, the 14-period RSI for Dermata Therapeutics stands at 47, indicating moderately negative momentum. This range suggests moderated price movement without extreme directional pressure.Momentum
Impartial
Oversold | Overbought |
This view frames how Dermata Therapeutics Warrant responds to recent headlines and peer activity within its market context.
The Simple Moving Average forecasted value of Dermata Therapeutics Warrant on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.0018 and the sum of the absolute errors of 0.11.Dermata Therapeutics after-hype prediction price | $ 0.02 |
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Use Historical Fundamental Analysis of Dermata Therapeutics to cross-verify projections for Dermata Therapeutics. The view provides historical context for the projection set.Dermata Therapeutics Additional Predictive Modules
Most predictive techniques to examine Dermata price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dermata using various technical indicators. When you analyze Dermata charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Dermata Therapeutics Simple Moving Average Price Forecast For the 12th of March 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Dermata Therapeutics Warrant on the next trading day is expected to be 0.02 with a mean absolute deviation of 0.0018 , mean absolute percentage error of 0.00000747 , and the sum of the absolute errors of 0.11 .Please note that although there have been many attempts to predict Dermata Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Dermata Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Dermata Therapeutics Stock Forecast Pattern
| Backtest Dermata Therapeutics | Dermata Therapeutics Price Prediction | Research Analysis |
Dermata Therapeutics Forecasted Value
This next-day forecast for Dermata Therapeutics Warrant uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Dermata Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Dermata Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 104.4679 |
| Bias | Arithmetic mean of the errors | 2.0E-4 |
| MAD | Mean absolute deviation | 0.0018 |
| MAPE | Mean absolute percentage error | 0.0936 |
| SAE | Sum of the absolute errors | 0.1095 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dermata Therapeutics' price to converge to an average value over time is called mean reversion.
Dermata Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Dermata Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range.
Next price density |
| Expected price to next headline |
Dermata Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Dermata Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dermata Therapeutics' historical news coverage.
Current Value
The after-hype framework applied to Dermata Therapeutics Warrant assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Dermata Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Dermata Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dermata Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dermata Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.75 | 13.77 | 0.01 | 0.00 | 4 Events | 3 Events | In 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.02 | 0.02 | 9.29 |
|
Dermata Therapeutics Hype Timeline
Dermata Therapeutics is currently traded for 0.02. The company has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.0. Dermata is forecasted to increase in value after the next headline, with the price projected to jump to 0.02 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 9.29%, whereas the daily expected return is currently at 0.75%. The volatility of related hype on Dermata Therapeutics is about 275400.0%, with the expected price after the next announcement by competition of 0.02. The company has return on total asset (ROA) of -96.46 % which suggests that the asset base is not productive at current operating levels. This is extremely low compared to the sector. Similarly, it shows a return on equity (ROE) of -203.36 %, which implies that returns to shareholders were negative during the period. Assuming a 90-day horizon the next forecasted press release will be in 4 days. Use Historical Fundamental Analysis of Dermata Therapeutics to cross-verify projections for Dermata Therapeutics. The view provides historical context for the projection set.Dermata Therapeutics Related Hype Analysis
Having access to credible news sources related to Dermata Therapeutics' direct competition is more important than ever and may enhance your ability to predict Dermata Therapeutics' future price movements. Getting to know how Dermata Therapeutics' peers react to changing market sentiment, related social.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| REVB | Revelation Biosciences | 0.06 | 8 per month | 0.00 | -0.25 | 5.56 | -10.16 | 34.09 | |
| VRPX | Virpax Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.13 | 0.00 | 0.00 | 1,989 | |
| VINC | Vincerx Pharma Common | 0.0001 | 1 per month | 3.76 | 0.14 | 2.50 | -2.44 | 127.90 | |
| PPBT | Purple Biotech | -0.12 | 4 per month | 0.00 | -0.21 | 7.74 | -7.05 | 19.93 | |
| SLXNW | Biomotion Sciences Warrant | 0.00 | 0 per month | 11.96 | 0.04 | 32.67 | -24.05 | 79.50 | |
| SYRS | Syros Pharmaceuticals | 0.00 | 0 per month | 32.76 | 0.26 | 300.00 | -75.00 | 375.00 | |
| FOXO | FOXO Technologies | -0.0001 | 3 per month | 0.00 | 0.08 | 100.00 | -50.00 | 150.00 | |
| AKTX | Akari Therapeutics PLC | -0.01 | 4 per month | 0.00 | -0.03 | 8.00 | -7.69 | 47.60 | |
| PIII | P3 Health Partners | 0.14 | 2 per month | 0.00 | -0.02 | 22.22 | -12.38 | 48.13 | |
| CDT | Conduit Pharmaceuticals | -0.02 | 7 per month | 0.00 | -0.17 | 12.43 | -10.58 | 40.12 |
Other Forecasting Options for Dermata Therapeutics
For every potential investor in Dermata, whether a beginner or expert, Dermata Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.Dermata Therapeutics Related Equities
The following equities are related to Dermata Therapeutics within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Dermata Therapeutics against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Dermata Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Dermata Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dermata Therapeutics shares will generate the highest return on.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.11 | |||
| Day Median Price | 0.0183 | |||
| Day Typical Price | 0.0183 | |||
| Price Action Indicator | 9.0E-4 | |||
| Period Momentum Indicator | 0.0018 | |||
| Relative Strength Index | 47.83 |
Dermata Therapeutics Risk Indicators
The analysis of Dermata Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dermata Therapeutics' investment and either accepting that risk or mitigating it.
| Mean Deviation | 9.29 | |||
| Semi Deviation | 12.62 | |||
| Standard Deviation | 13.76 | |||
| Variance | 189.36 | |||
| Downside Variance | 219.07 | |||
| Semi Variance | 159.24 | |||
| Expected Short fall | -10.50 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Dermata Therapeutics
Coverage intensity for Dermata Therapeutics Warrant matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Dermata Therapeutics Short Properties
Short sentiment tied to Dermata Therapeutics Warrant matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 153 K | |
| Cash And Short Term Investments | 3.2 M |
Additional Tools for Dermata Stock Analysis
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |